Comparison of adjunctive naoxintong versus clopidogrel in volunteers with the CYP2C19 * 2 gene mutation accompanied with qi deficiency and blood stasis constitution

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Chen, Hui ^a,b   Yu, Guangwei ^a   Sun, Hong ^c   Wu, Xiaoying ^a   Wang, Huan ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUJIAN NORMAL UNIVERSITY   (China)

^c FUJIAN PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BUCHANG NAOXINTONG JIAONANG; CHINESE DRUG; CLOPIDOGREL; CYTOCHROME P450 2C19; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADULT; CHINESE MEDICINE; FEMALE; GENE MUTATION; GENOTYPE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN DISEASE; THROMBOCYTE AGGREGATION;

EID: 79955165371     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/207034     Document Type: Review

References (27)

1. Holmes D. R., ACCF/AHA clopidogrel clinical alert: approaches to the FDA boxed warning: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Journal of the American College of Cardiology 2010 56 321 341
2. Collet J.-P., Hulot J.-S., Pena A., Villard E., Esteve J.-B., Silvain J., Payot L., Brugier D., Cayla G., Beygui F., Bensimon G., Funck-Brentano C., Montalescot G., Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study The Lancet 2009 373 9660 309 317
3. Trenk D., Hochholzer W., Fromm M. F., Chialda L. E., Pahl A., Valina C. M., Stratz C., Schmiebusch P., Bestehorn H. P., Bttner H. J., Neumann F. J., Cytochrome P450 2C19 681G A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents Journal of the American College of Cardiology 2008 51 20 1925 1934 (Pubitemid 351636443)
4. Mega J. L., Close S. L., Wiviott S. D., Shen L., Hockett R. D., Brandt J. T., Walker J. R., Antman E. M., Macias W., Braunwald E., Sabatine M. S., Cytochrome P-450 polymorphisms and response to clopidogrel New England Journal of Medicine 2009 360 4 354 362
5. Shuldiner A. R., O'Connell J. R., Bliden K. P., Gandhi A., Ryan K., Horenstein R. B., Damcott C. M., Pakyz R., Tantry U. S., Gibson Q., Pollin T. I., Post W., Parsa A., Mitchell B. D., Faraday N., Herzog W., Gurbel P. A., Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy Journal of the American Medical Association 2009 302 8 849 858
6. Fontana P., Senouf D., Mach F., Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C192 allele on clopidogrel responsiveness Thrombosis Research 2008 121 4 463 468 (Pubitemid 351174278)
7. Tavassoli N., Voisin S., Carrie D., Lapeyre-Mestre M., Galinier M., Montastruc J. L., Pathak A., High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients American Journal of Cardiovascular Drugs 2010 10 1 29 35
8. Jeong Y. H., Lee S. W., Choi B. R., Kim I. S., Seo M. K., Kwak C. H., Hwang J. Y., Park S. W., Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance (ACCEL-RESISTANCE) randomized study Journal of the American College of Cardiology 2009 53 13 1101 1109
9. Wallentin L., Varenhorst C., James S., Erlinge D., Braun O. O., Jakubowski J. A., Sugidachi A., Winters K. J., Siegbahn A., Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease European Heart Journal 2008 29 1 21 30
10. Ben-Dor I., Torguson R., Scheinowitz M., Li Y., Delhaye C., Wakabayashi K., Maluenda G., Syed A. I., Collins S. D., Gonzalez M. A., Gaglia M. A., Xue Z., Kaneshige K., Satler L. F., Suddath W. O., Kent K. M., Pichard A. D., Waksman R., Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents American Heart Journal 2010 159 5 871 875
11. Sibbing D., Schulz S., Braun S., Morath T., Stegherr J., Mehilli J., Schmig A., Von Beckerath N., Kastrati A., Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement Journal of Thrombosis and Haemostasis 2010 8 2 250 256
12. Lardizabal J. A., Joshi B. K., Ambrose J. A., The balance between anti-ischemic efficacy and bleeding risk of antithrombotic therapy in percutaneous coronary intervention: a Yin-Yang paradigm Journal of Invasive Cardiology 2010 22 6 284 292
13. Chen B. J., Pan Z. Q., Su X. X., Study on changes of TCM syndrome in patients with coronary heart disease before and after intervention treatment Zhongguo Zhong Xi Yi Jie He Za Zhi 2007 27 689 691
14. Wang J., Chu F. Y., Li J., Yao K. W., Zhong J. B., Zhou K. H., He Q. Y., Sun X. W., Study on syndrome element characteristics and its correlation with coronary angiography in 324 patients with coronary heart disease Chinese Journal of Integrative Medicine 2008 14 4 274 280
15. Chen C., Venketasubramanian N., Gan R. N., Lambert C., Picard D., Chan B. P. L., Chan E., Bousser M. G., Xuemin S., Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery Stroke 2009 40 3 859 863
16. Zhang H., Wang W. R., Lin R., Zhang JI. Y., Ji Q. L., Lin Q. Q., Yang LI. N., Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats Journal of Ethnopharmacology 2010 130 1 98 102
17. Chen D. K., Zhang H. Q., Zhang J. H., Intervening effect of naoxintong on anti-platelet treatment with aspirin Zhongguo Zhong Xi Yi Jie He Za Zhi 2008 28 9 843 846
18. Wang Q., Classification and diagnosis basis of nine basic constitutions in Chinese medicine Journal of Beijing University of Traditional Chinese Medicine 2005 28 4 1 8
19. Wang Q., Yao S., Molecular basis for cold-intolerant yang-deficient constitution of traditional chinese medicine American Journal of Chinese Medicine 2008 36 5 827 834
20. Born G. V. R., Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 1962 194 4832 927 929
21. Chen B. L., Zhang W., Li Q., Li Y. L., He YI. J., Fan L., Wang L. S., Liu Z. Q., Zhou H. H., Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms Clinical and Experimental Pharmacology and Physiology 2008 35 8 904 908 (Pubitemid 351953054)
22. Mega J. L., Close S. L., Wiviott S. D., Shen L., Hockett R. D., Brandt J. T., Walker J. R., Antman E. M., Macias W., Braunwald E., Sabatine M. S., Cytochrome P-450 polymorphisms and response to clopidogrel New England Journal of Medicine 2009 360 4 354 362
23. Gilard M., Arnaud B., Cornily J. C., Le Gal G., Lacut K., Le Calvez G., Mansourati J., Mottier D., Abgrall J. F., Boschat J., Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin. The randomized, double-blind Omeprazole CLopidogrel Aspirin (OCLA) study Journal of the American College of Cardiology 2008 51 3 256 260
24. Liu G. F., Guo X. L., Advances in studies on regulation of Chinese materia medica on cytochrome P450 system Chinese Traditional and Herbal Drugs 2008 39 1 139 143
25. Chan E., Tan M., Xin J., Sudarsanam S., Johnson D. E., Interactions between traditional Chinese medicines and Western therapeutics Current Opinion in Drug Discovery and Development 2010 13 1 50 65
26. Wang D., Sheng L. S., Song Y., Li P., Determination of eight astragalosides in BuChang Naoxintong Capsule by HPLC-MS Chinese Journal of Natural Medicines 2006 4 4 287 290 (Pubitemid 44150860)
27. Xia X. Y., Peng R. X., Kong R., Effects of angelica sinensis polysaccharides on hepatic drug metabolism enzymes activities in mice Chinese Journal of Chinese Materia Medica 2003 28 2 149 152